Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arbutus Biopharma Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ABUS
Nasdaq
8731
https://www.arbutusbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arbutus Biopharma Corp
Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
- May 3rd, 2024 10:39 am
Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
- May 3rd, 2024 7:24 am
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
- May 2nd, 2024 12:58 pm
Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
- May 2nd, 2024 12:45 pm
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
- May 2nd, 2024 11:30 am
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
- May 2nd, 2024 11:25 am
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
- Apr 30th, 2024 1:40 pm
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
- Apr 18th, 2024 11:30 am
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
- Apr 4th, 2024 12:30 pm
Is Arbutus Biopharma (NASDAQ:ABUS) In A Good Position To Deliver On Growth Plans?
- Apr 1st, 2024 4:44 pm
Arbutus to Participate in Two Upcoming Investor Conferences
- Mar 8th, 2024 12:30 pm
Arbutus Biopharma Corporation (NASDAQ:ABUS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
- Mar 3rd, 2024 12:38 pm
Analysts Just Made A Major Revision To Their Arbutus Biopharma Corporation (NASDAQ:ABUS) Revenue Forecasts
- Mar 2nd, 2024 12:29 pm
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript
- Mar 1st, 2024 1:17 pm
Q4 2023 Arbutus Biopharma Corp Earnings Call
- Mar 1st, 2024 4:14 am
Arbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
- Feb 29th, 2024 1:40 pm
Arbutus Biopharma Corp (ABUS) Reports Year-End Financial Results and Progress in Clinical Trials
- Feb 29th, 2024 12:52 pm
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
- Feb 29th, 2024 12:30 pm
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
- Feb 15th, 2024 12:30 pm
The past three years for Arbutus Biopharma (NASDAQ:ABUS) investors has not been profitable
- Feb 2nd, 2024 3:29 pm
Scroll